Short-term, high-dose prednisolone doesn't raise diabetes risk in RA patients

03/21/2012 |

Short-term treatment with 60 mg or 30 mg per day of prednisolone, a type of corticosteroid, did not appear to lower glucose tolerance in rheumatoid arthritis patients, including those with impaired glucose metabolism or type 2 diabetes. The study in Arthritis & Rheumatism also found that patients who took prednisolone had improvements in C-reactive protein levels and, for those on the 60 mg per day dose, improved beta cell function.

View Full Article in:

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID